Pharma & Biotech

Eli Lilly & Co. has demonstrated remarkable market performance this week, propelled by growing confidence in the pharmaceutical giant's weight-loss...

Phathom Pharmaceuticals is demonstrating remarkable momentum in the market, fueled by unexpectedly robust quarterly earnings and significant clinical development milestones....

The independent journey of Verve Therapeutics on public markets concluded on July 25, 2025, when the biotechnology firm was officially...

The pharmaceutical industry continues to scrutinize Vertex Pharmaceuticals' landmark acquisition of Alpine Immune Sciences, a transaction valued at $4.9 billion...

Biotechnology firm Ocugen Inc. finds itself navigating a critical juncture. While the company's latest earnings report revealed substantial revenue growth,...

Eli Lilly and Company has positioned itself for substantial expansion through a series of strategic developments announced in early November...

While NextCure shares extended their positive momentum with a fourth consecutive day of gains, underlying technical indicators reveal concerning divergences...

The biotechnology firm Lyra Therapeutics Inc finds itself navigating turbulent waters, with its equity valuation under severe pressure. A combination...

The French vaccine developer Valneva has staged an impressive financial recovery, transforming a €69.3 million loss into a substantial €24.7...

Redcare Pharmacy shares are navigating turbulent waters, having shed more than half their value since the start of the year...